BREWIN DOLPHIN LTD - AMPIO PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
BREWIN DOLPHIN LTD ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$6,367
+42.3%
11,3300.0%0.00%0.0%
Q4 2018$4,473
-22.3%
11,3300.0%0.00%0.0%
Q3 2018$5,756
-76.9%
11,3300.0%0.00%
-66.7%
Q2 2018$24,92611,3300.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 2,595,484$10,564,0009.31%
Cypress Capital Management LLC (WY) 108,400$441,0000.50%
Noven Financial Group, Inc. 158,059$643,0000.37%
Transform Wealth, LLC 205,481$836,0000.15%
GHP Investment Advisors, Inc. 100,000$407,0000.06%
Pratt Collard Advisory Partners LLC 15,600$63,0000.05%
JANICZEK WEALTH MANAGEMENT, LLC 16,719$68,0000.04%
Virtu Financial LLC 92,344$376,0000.02%
JFS WEALTH ADVISORS, LLC 18,150$74,0000.02%
CONDOR CAPITAL MANAGEMENT 21,400$87,0000.02%
View complete list of AMPIO PHARMACEUTICALS INC shareholders